Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$4.58 - $8.34 $53,086 - $96,668
-11,591 Closed
0 $0
Q3 2021

Jun 21, 2023

BUY
$8.44 - $18.35 $97,828 - $212,694
11,591 New
11,591 $98,000
Q2 2021

Jun 21, 2023

BUY
$16.41 - $24.71 $190,208 - $286,413
11,591 New
11,591 $190,000
Q1 2021

May 17, 2024

BUY
$20.38 - $34.07 $236,224 - $394,905
11,591 New
11,591 $255,000
Q1 2021

Jun 26, 2023

BUY
$20.38 - $34.07 $236,224 - $394,905
11,591 New
11,591 $256 Million
Q4 2020

Jun 22, 2023

BUY
$19.0 - $32.63 $220,229 - $378,214
11,591 New
11,591 $358,000
Q3 2020

May 24, 2024

BUY
$13.1 - $20.69 $44,278 - $69,932
3,380 Added 41.16%
11,591 $236 Million
Q3 2020

Jun 26, 2023

BUY
$13.1 - $20.69 $151,842 - $239,817
11,591 New
11,591 $235,000
Q3 2020

Mar 22, 2023

BUY
$13.1 - $20.69 $44,278 - $69,932
3,380 Added 41.16%
11,591 $235,000
Q3 2020

Nov 13, 2020

BUY
$13.1 - $20.69 $44,278 - $69,932
3,380 Added 41.16%
11,591 $236,000
Q2 2020

May 24, 2024

BUY
$6.51 - $16.85 $53,453 - $138,355
8,211 New
8,211 $126 Million
Q2 2020

Jun 26, 2023

BUY
$6.51 - $16.85 $53,453 - $138,355
8,211 New
8,211 $126,000
Q2 2020

Mar 22, 2023

BUY
$6.51 - $16.85 $53,453 - $138,355
8,211 New
8,211 $126,000
Q2 2020

Aug 14, 2020

BUY
$6.51 - $16.85 $53,453 - $138,355
8,211 New
8,211 $126,000

About TCR2 THERAPEUTICS INC.


  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.